Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes

被引：9
|
作者：
Hickman, Ingrid J. [1 ]
Whitehead, Jonathan P. [1 ]
Prins, Johannes B. [1 ]
Macdonald, Graeme A. [1 ]
机构：
[1] Univ Queensland, Princess Alexandra Hosp, CDER, Woolloongabba, Qld 4102, Australia
来源：
DIABETES OBESITY & METABOLISM | 2007年 / 9卷 / 03期
关键词：
adiponectin; BMI; insulin resistance; liver injury; NAFLD;
D O I：
10.1111/j.1463-1326.2006.00604.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aim: The aim of the study was to investigate the relationship between the metabolic syndrome (MS), adiponectin and abnormal liver enzymes in patients with type 2 diabetes. Methods: Fasting serum was collected from 189 patients with type 2 diabetes, adiponectin was measure using radioimmunoassay and features of the MS were assessed. Results: Mean ALT was significantly higher in patients with the MS and higher ALT was associated with lower adiponectin levels. As the number of features of MS increased, ALT increased and adiponectin decreased independent of glycaemic control. Conclusion: Hypoadiponectinemia and the MS may be linked with liver injury in patients with type 2 diabetes.
引用
收藏
页码：438 / 440
页数：3
相关论文
共 50 条
  • [41] The genes influencing adiponectin levels also influence risk factors for metabolic syndrome and type 2 diabetes
    Comuzzie, Anthony G.
    Tejero, M. Elizabeth
    Funahashi, Tohru
    Martin, Lisa J.
    Kissebah, Ahmed
    Takahashi, Masahiko
    Kihara, Shinji
    Tanaka, Sachiyo
    Rainwater, David L.
    Matsuzawa, Yuji
    Maccluer, Jean W.
    Blangero, John
    HUMAN BIOLOGY, 2007, 79 (02) : 191 - 200
  • [42] Relationship between adiponectin and metabolic variables in Caribbean offspring of patients with type 2 diabetes mellitus
    Ezenwaka, CE
    Kalloo, R
    Uhlig, M
    Eckel, J
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (04) : 238 - 242
  • [43] Decreased splanchnic adiponectin release contributes to lower plasma adiponectin concentrations in type 2 diabetes mellitus
    Basu, R
    Pajvani, UB
    Rizza, RA
    Scherer, PE
    DIABETES, 2004, 53 : A80 - A80
  • [44] Type 2 Diabetes in Octogenarians Is Associated with Decreased Low Molecular Weight Adiponectin
    Graessler, Juergen
    Gruber, Matthias
    Radke, Rolf-Bernd
    Kopprasch, Steffi
    Schwarz, Peter E. H.
    Kamke, Wolfram
    Bornstein, Stefan R.
    Fischer, Sabine
    GERONTOLOGY, 2011, 57 (04) : 316 - 326
  • [45] CARDIOMETABOLIC RISK ASSOCIATED WITH METABOLIC SYNDROME IN TYPE 2 DIABETES PATIENTS
    Torrea, M.
    Aladeazabal, N.
    Lopez Berastegui, O. L. G. A.
    Pinilla, B.
    Muino, A.
    Millan, J.
    ATHEROSCLEROSIS, 2014, 235 (02) : E237 - E238
  • [46] Pathophysiology of dyslipidemia in patients with metabolic syndrome or type 2 diabetes mellitus
    Verges, Bruno
    NUTRITION CLINIQUE ET METABOLISME, 2007, 21 (01): : 9 - 16
  • [47] Metabolic syndrome and pharmacotherapy outcomes in patients with type 2 diabetes mellitus
    Alawdi, Shawqi H.
    Al-Dholae, Mohammed
    Al-Shawky, Salah
    FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE, 2024, 5
  • [48] Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes
    Orna, JAG
    Arnal, LML
    Herguedas, EM
    Julián, BB
    Córdoba, DPP
    REVISTA ESPANOLA DE CARDIOLOGIA, 2004, 57 (06): : 507 - 513
  • [49] Lifestyle and quality of life in patients with metabolic syndrome and type 2 diabetes
    Alexandra Granados-Vidal, Yenny
    Jimena Jacome-Velasco, Sandra
    Paternina-De la Ossa, Aura
    Galvis-Fernandez, Brigid
    Villaquiran-Hurtado, Andres
    DUAZARY, 2019, 16 (03) : 25 - 39
  • [50] Serum Alanine Transaminase as a Predictor of Type 2 Diabetes Incidence: The Yuport Prospective Cohort Study
    Hatano, Yu
    Inoue, Kazuo
    Kashima, Saori
    Matsumoto, Masatoshi
    Akimoto, Kimihiko
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 251 (03): : 183 - 191
12345